The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Open accessAbstract
Aims A new human coronavirus (HCoV), which has been designated SARS-CoV-2, began spreading in December 2019 in Wuhan City, China causing pneumonia called COVID-19. The spread of SARS-CoV-2 has been faster than any other coronaviruses that have succeeded in crossing the animal-human barrier. There is concern that this new virus will spread around the world as did the previous two HCoVs—Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)—each of which caused approximately 800 deaths in the years 2002 and 2012, respectively. Thus far, 11,268 deaths have been reported from the 258,842 confirmed infections in 168 countries. Main methods In this study, the RNA-dependent RNA polymerase (RdRp) of the newly emerged coronavirus is modeled, validated, and then targeted using different anti-polymerase drugs currently on the market that have been approved for use against various viruses. Key findings The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp. In addition, the results suggest guanosine derivative (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically. Significance The availability of FDA-approved anti-RdRp drugs can help treat patients and reduce the danger of the mysterious new viral infection COVID-19. The drugs mentioned above can tightly bind to the RdRp of the SARS-CoV-2 strain and thus may be used to treat the disease. No toxicity measurements are required for these drugs since they were previously tested prior to their approval by the FDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density-functional thermochemistry. III. The role of exact exchange
Becke, A. D. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464913 · Cited by 103,767
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku340 · Cited by 4,632
MolProbity: More and better reference data for improved all‐atom structure validation
Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., et al. (2018) · Protein Science · doi:10.1002/pro.3330 · Cited by 4,599
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Stewart, J. J. P. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-007-0233-4 · Cited by 3,619
Announcing the worldwide Protein Data Bank
Berman, H., Henrick, K., & Nakamura, H. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1203-980 · Cited by 3,093
PLIP: fully automated protein–ligand interaction profiler
Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv315 · Cited by 2,340
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
[20] VERIFY3D: Assessment of protein models with three-dimensional profiles
Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77022-8 · Cited by 2,192
Hooft, R. W. W., Vriend, G., Sander, C., & Abola, E. E. (1996) · Nature · doi:10.1038/381272a0 · Cited by 2,173
Molecular Modelling: Principles and Applications
Leach, A. R. (1996) · Cited by 1,945
Molecular Modelling: Principles and Applications
Valverde, J. R. (2001) · Briefings in Bioinformatics · doi:10.1093/bib/2.2.199 · Cited by 1,842
Bogoch, I. I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M. U. G., & Khan, K. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa008 · Cited by 898
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
Kirchdoerfer, R. N., & Ward, A. B. (2019) · Nature Communications · doi:10.1038/s41467-019-10280-3 · Cited by 896
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Deviations from Standard Atomic Volumes as a Quality Measure for Protein Crystal Structures
Pontius, J., Richelle, J., & Wodak, S. J. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0628 · Cited by 736
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Elfiky, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117477 · Cited by 715
Self-citationCOVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.026 · Cited by 509
Self-citationMiddle East Respiratory Syndrome Coronavirus (MERS-CoV)
Jolly, G. (2016) · TEXILA INTERNATIONAL JOURNAL OF PUBLIC HEALTH · doi:10.21522/tijph.2013.04.04.art033 · Cited by 441
The Middle East Respiratory Syndrome Coronavirus ( MERS - COV )
Jahan, F., & Al Maqbali, A. A. (2015) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2015.92625 · Cited by 334
The mechanism of action of T7 DNA polymerase
Doublié, S., & Ellenberger, T. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80089-4 · Cited by 193
Báez-Santos, Y. M., Mielech, A. M., Deng, X., Baker, S. C., & Mesecar, A. D. (2014) · Journal of Virology · doi:10.1128/jvi.01294-14 · Cited by 133
Elfiky, A. A., Mahdy, S. M., & Elshemey, W. M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24736 · Cited by 128
Self-citationZika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
Elfiky, A. A. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24678 · Cited by 81
Self-citationSome One Health based control strategies for the Middle East respiratory syndrome coronavirus
Hemida, M. G., & Alnaeem, A. A. (2019) · One Health · doi:10.1016/j.onehlt.2019.100102 · Cited by 57
Pneumonia in China: lack of information raises concerns among Hong Kong health workers
Parry, J. (2020) · BMJ · doi:10.1136/bmj.m56 · Cited by 55
Applications of computer-aided approaches in the development of hepatitis C antiviral agents
Ganesan, A., & Barakat, K. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1291628 · Cited by 54
Elfiky, A. A., & Elshemey, W. M. (2017) · Journal of Medical Virology · doi:10.1002/jmv.24934 · Cited by 54
Self-citationElfiky, A. A., & Ismail, A. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116958 · Cited by 52
Self-citationElfiky, A. A., & Ismail, A. M. (2018) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2018.1454981 · Cited by 43
Self-citationStructural properties of metal-free apometallothioneins
Summers, K. L., Mahrok, A. K., Dryden, M. D. M., & Stillman, M. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.141 · Cited by 39
Elfiky, A. A. (2017) · Future Virology · doi:10.2217/fvl-2017-0081 · Cited by 36
Self-citation
Cited by
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,114
SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
Veras, F. P., Pontelli, M. C., Silva, C. M., Toller-Kawahisa, J. E., de Lima, M., Nascimento, D. C., Schneider, A. H., Caetité, D., Tavares, L. A., Paiva, I. M., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201129 · Cited by 933
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532
COVID-19 in Immunocompromised Hosts: What We Know So Far
Fung, M., & Babik, J. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa863 · Cited by 526
Metadata
- Authors
- Elfiky, A. A.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 253
- Pages
- 117592
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W3012588029
- Cited by
- 923
- References
- 36
- FWCI
- 98.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.